Skip to content

Pirtobrutinib

Brand name: Jaypirca

Pirtobrutinib comes in 4 pill versions in our database, in 2 strengths, from 2 manufacturers. Check the imprint to tell them apart.

Pirtobrutinib pill images

50 mg 2 pills

100 mg 2 pills

What is Pirtobrutinib used for?

Pirtobrutinib is used for mantle-cell lymphoma.

Medicine type
Cancer medicine (kinase inhibitor)
Official uses from the US prescribing label

Mantle Cell Lymphoma

JAYPIRCA® is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (MCL) after at least two lines of systemic therapy, including a BTK inhibitor.

This indication is approved under accelerated approval based on response rate. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial.

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

JAYPIRCA is indicated for the treatment of adult patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) who have previously been treated with a covalent BTK inhibitor.

From the FDA-approved label on DailyMed (published Mar 25, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.